K. Shibata

发表

Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis

S. Sakisaka, Takashi Tanaka, D. Morihara, 2018, Clinical and molecular hepatology.

Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites

S. Sakisaka, F. Hirai, Takashi Tanaka, 2022, Medicina.

Proteomic analysis of Atg8-dependent recruitment of phagosomal proteins in the enteric protozoan parasite Entamoeba histolytica

T. Nozaki, K. Nakada-Tsukui, Natsuki Watanabe, 2022, Frontiers in Cellular and Infection Microbiology.

Long-term outcomes of hemostatic therapy for variceal bleeding and the challenge pending in the post-direct-acting antivirals era.

S. Sakisaka, K. Takata, K. Yokoyama, 2022, Acta gastro-enterologica Belgica.

Long-Term Outcomes of Hemostatic Therapy for Gastrointestinal Variceal Bleeding and the Transition of Hemostatic Therapy: A Retrospective Study

S. Sakisaka, F. Hirai, Takashi Tanaka, 2020 .

Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension

S. Sakisaka, F. Hirai, Takashi Tanaka, 2020, Internal medicine.

Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus Infection

S. Sakisaka, Takashi Tanaka, D. Morihara, 2018, Nutrients.

IL28B gene polymorphism is correlated with changes in low‐density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct‐acting antiviral treatment

T. Sohda, S. Sakisaka, Takashi Tanaka, 2019, Journal of gastroenterology and hepatology.

Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameter

S. Sakisaka, K. Takata, K. Yokoyama, 2023, Scientific reports.

Two cases of severe oral mucositis caused by atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma.

K. Takata, K. Yokoyama, S. Shakado, 2024, Clinical journal of gastroenterology.